Healthcare

Antibody Drug Conjugates Market by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast Cancer and Lymphoma) - Global Opportunity Analysis and Industry Forecast 2017-2023

  • ALL1548465
  • 152 Pages
  • September 2017
  • Healthcare

The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023. Antibody drug conjugates (ADC’s) are promising and effective anticancer medications employed for efficient treatment of cancer patients. ADC’s are biopharmaceutical drugs prepared by integrating two clinical approaches viz cell killing HPAPI (powerful pharmaceutical ingredient) and monoclonal antibody specificity. This combination approach enables elimination of cancer infected cells without harming healthy cells in patient’s body. 

Increase in global prevalence of cancer and demand for quality & cost-effective cancer medications drives the global ADCs market. In addition, extensive R&D for cancer medication and approval of new cancer drugs is expected to boost the market growth during the forecast period. However, high cost involved in R&D of cancer medication and stringent government regulations impedes the growth of antibody drug conjugates market. 

The report segments the market based on drugs, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla. Based on mechanism of action, it is divided into CD30 antibodies and HER2 antibodies. Based on application, the market is classified into breast cancer, lymphoma, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS

  •  The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  •  It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  •  Extensive analysis by product elucidates the various types of ADC’s used for diverse cancer therapeutic procedures
  •  Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  •  Key players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global ADCs market.

KEY PLAYERS PROFILED

  •  F. Hoffman-La Roche Ltd.
  •  Novartis AG
  •  Takeda Pharmaceutical Company Limited
  •  Pfizer, Inc.
  •  Seattle Genetics Inc.
  •  Genentech Inc.
  •  Immunogen Inc.
  •  Immunomedics, Inc.
  •  Progenics Pharmaceuticals Inc. 
  •  Bayer AG

KEY MARKET SEGMENTS

BY DRUGS

  •  Adcetris 
  •  Kadcyla

BY MECHANISM OF ACTION

  •  CD30 Antibodies
  •  HER2 Antibodies

BY APPLICATION

  •  Breast Cancer
  •  Lymphoma

By Region

  •  North America
    •  U.S.
    •  Canada
    •  Mexico
  •  Europe
    •  France 
    •  Germany 
    •  UK 
    •  Italy 
    •  Spain 
    •  The Netherlands 
    •  Norway
    •  Russia 
    •  Sweden
    •  Switzerland 
    •  Rest of Europe
  •  Asia-Pacific
    •  Japan 
    •  China 
    •  India 
    •  Australia 
    •  South Korea 
    •  New Zealand 
    •  Taiwan 
    •  Thailand 
    •  Rest of Asia-Pacific 
  •  LAMEA
    •  Brazil 
    •  Saudi Arabia 
    •  South Africa 
    •  Chile 
    •  Columbia 
    •  Egypt 
    •  Iran 
    •  Israel 
    •  Turkey 
    •  Venezuela 
    •  Rest of LAMEA 

The other players of the anesthesia market include (companies not profiled in the report):

  •  Agensys, Inc. 
  •  Concortis Biotherapeutics
  •  Sanofi S.A.
  •  Celldex Therapeutics Inc. 
  •  Synthon Holding B.V.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

U.S. NPWT Devices Market - Opportunities and Forecast, 2015 - 2020

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove ...

January2018| $2850 | Pre Book Price:$2494

Asian Chromatography Solvents Market - Opportunities and Forecasts, 2015 - 2020

Chromatography is a technique used for separation of mixtures for advanced use. Chromatography solvents, such as methanol, chloroform, ethanol, and others are used for separation of mixtures. One component solvent ...

January2018| $2850 | Pre Book Price:$2494

Intra-Dialytic Hypotension (IDH) Asia-Pacific Market Research Report, 2013 - 2020

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ≥20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, ...

January2018| $2850 | Pre Book Price:$2494

Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

January2018| $2850 | Pre Book Price:$2494

European Dermatology Diagnostic Devices Market- Opportunities and Forecasts, 2014 - 2020

The healthcare sector across Europe is witnessing a dramatic shift and is inclined towards less invasive diagnostic procedures. Dermatology diagnostic equipment aids in both easy as well as painless diagnosis. ...

January2018| $3390 | Pre Book Price:$2967

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

January2018| $2850 | Pre Book Price:$2494

2017 © Copyright Big Market Research

View Pricing >>